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Abstract. 
 Wilms’ tumours, paediatric kidney cancers, are the archetypal example of tumours 
caused through the disruption of normal development. The genetically best defined subgroup 
of Wilms’ tumours is the group caused by biallelic loss of the WT1 tumour suppressor gene. 
Here we describe a developmental series of mouse models with conditional loss of Wt1 in 
different stages of nephron development before and after the mesenchymal to epithelial 
transition (MET). We demonstrate that Wt1 is essential for normal development at all kidney 
developmental stages under study. Comparison of genome-wide expression data from the 
mutant mouse models to human tumour material of WT1-mutant and WT1 wild-type datasets 
identifies the stage of origin of human WT1-mutant tumours, and emphasizes fundamental 
differences between the two human tumour groups due to different developmental stages of 
origin.  
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Introduction. 
Wilms’ tumours (Wilms, 1899) is a paediatric kidney cancer that affects 1:10,000 
children, usually before the age of five (recently reviewed in Hohenstein et al., 2015) . They 
are thought to be caused by a block in the normal development of nephrons, as illustrated by 
the appearance of nephrogenic rests; structures resembling embryonic renal tissues and 
believed to be the first stage of Wilms’ tumour development. Therefore, to truly understand the 
development of Wilms’ tumour, a full understanding of normal kidney development and the 
role of genes linked to Wilms’ tumourigenesis in this process is essential.   
The developing metanephric kidney is a model system for many developmental 
processes, involving reciprocal inductions between different cell types, mesenchymal to 
epithelial transitions and patterning (Saxen, 1987). The initiating event in this process is the 
invasion of the ureteric bud, an epithelial outgrowth of the Wolffian duct, into the metanephric 
mesenchyme, which is a derivative of the intermediate mesoderm. In response, signals are 
exchanged bidirectionally between these populations resulting in the first branching of the 
ureteric bud and the formation of a condensate of mesenchymal cells, the cap mesenchyme, 
around the tips of the ureteric bud. Expression of Six2 in the cap mesenchyme labels the 
nephron progenitor cells (Kobayashi et al., 2008). A canonical Wnt signal, probably emanating 
from Wnt9b expressed in the ureteric bud, determines which of the Six2-positive cells remain 
in the progenitor cell state and which will differentiate to form the nephron (Karner et al., 2011; 
Park et al., 2012). A Yap-Fat4 mediated signal originating from Foxd1-positive stromal cells 
further controls this decision (Das et al., 2013). The cells that are induced to differentiate 
undergo a mesenchymal-to-epithelial transition (MET) under control of Wnt4 (Kispert et al., 
1998; Stark et al., 1994) to form the epithelialized renal vesicle, probably mediated by the non-
canonical Wnt-Ca2+-NFAT pathway (Burn et al., 2011; Tanigawa et al., 2011). Disruption of 
this MET is believed to be a central event in the development of Wilms’ tumours (Hohenstein 
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et al., 2015). The renal vesicle becomes patterned along the proximal-distal axis, connects to 
the ureteric bud at its distal end and through the comma and S-shaped body stages develops 
into the mature nephron consisting of distal tubule, loop of Henle, proximal tubule and the 
glomerulus, containing the filtering podocytes. This nephron induction, differentiation and 
maturation process is repeated every time the ureteric bud branches and new tips are formed.  
Wilms’ tumours were one of the cancers which Alfred Knudson used to develop the 
two-hit model and concept of tumour suppressor genes (Knudson and Strong, 1972). This led 
to the identification of the WT1 tumour suppressor gene, which loss is the rate-limiting step in 
15% of Wilms’ tumours (Hohenstein et al., 2015). This subset of cases is characterised by 
ectopic muscle development (Miyagawa et al., 1998; Schumacher et al., 2003) and selection 
for activating mutations in CTNNB1, the gene encoding β-catenin (Koesters et al., 1999; Maiti 
et al., 2000). Accordingly, the WT1 wild-type and mutant subsets of tumours can clearly be 
recognized using genome-wide expression analysis (Corbin et al., 2009; Gadd et al., 2012; Li 
et al., 2004). The genetics of WT1-wild-type tumours are less clear. Activation of the IGF2 
pathway through loss of heterozygosity (LOH) or loss of imprinting (LOI) has been identified 
in many of these cases, but it is unclear if this is the initiating event in these cases (Hohenstein 
et al., 2015). WTX was identified as a Wilms’ tumour gene on the X chromosome (Rivera et 
al., 2007), but the details of WTX-loss involvement in the origins of Wilms’ tumours have been 
disputed (Perotti et al., 2008; Rivera et al., 2007; Wegert et al., 2009). In all, WT1 remains the 
best genetic and molecular entry point to study the origins of and mechanisms leading to 
Wilms’ tumours. 
WT1 is expressed throughout nephron development (Armstrong et al., 1993; Pritchard-
Jones et al., 1990). The earliest expression in the renal lineage is found in the intermediate 
mesoderm. Subsequent, expression is found in the metanephric mesenchyme and cap 
mesenchyme. After the MET its expression becomes restricted to the proximal end of the 
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developing nephron until in the mature nephron it is only found in the podocytes. The WT1 
gene encodes a collection of at least 36 multi-functional isoforms involved in translation, RNA 
metabolism and transcriptional control (Hohenstein and Hastie, 2006). In the intermediate 
mesenchyme it has a pro-survival function, as these cells go into complete apoptosis in the 
conventional Wt1 knockout mouse (Kreidberg et al., 1993). In later stages the gene has been 
linked to control of the MET (Davies et al., 2004; Essafi et al., 2011). Wt1 has essential 
functions in the development of podocytes, as shown in mouse models and human syndromes 
(Gao et al., 2004; Miller-Hodges and Hohenstein, 2012; Ozdemir and Hohenstein, 2014) as 
well as the maintenance and function of mature podocytes as we showed by knocking out Wt1 
in adult mice (Chau et al., 2011). However, the role of Wt1 in the developmental stages between 
cap mesenchyme and podocyte is less clear. 
To start elucidating the events that lead to Wilms’ tumour formation we analysed the 
role of Wt1 before and after the MET, one of the candidate stages of origin of the tumours. Our 
data show that the loss of Wt1 at different stages during nephron development results in 
different phenotypes. Comparison of genome-wide expression data of these mutants to Wilms’ 
tumour microarray data suggests the stages of origin of the WT1-mutant and WT1 wild-type 
tumour sub-sets and further highlights their different developmental characteristics. 
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Results. 
 
Loss of Wt1 with different nephron Cre drivers results in different renal phenotypes. 
To knock-out Wt1 in different cell types during renal development, we selected three 
Cre strains and characterized them in the embryonic kidney through lineage tracing using time-
lapse imaging (Watanabe and Costantini, 2004) and an eYFP-based Cre reporter (Srinivas et 
al., 2001). Nes, the gene encoding the intermediate filament protein Nestin, is expressed at least 
as early as E12.5 in the embryonic kidney mesenchyme and is probably a direct transcriptional 
target for Wt1 (Wagner et al., 2006). Accordingly, the Nes-Cre allele we used (Tronche et al., 
1999) showed widespread activity in the mesenchyme at E11.5. During subsequent culturing, 
the lineage trace was restricted to the nephrogenic lineage and excluded from the ureteric bud 
(Fig. 1A and Supp. Movie 1A). Initially, there is a parallel and evenly spaced movement of 
labelled cap mesenchymes, as if being ‘pushed out’ by the ureteric bud; later during the cultures 
there appears to be a steady stream of labelled cells from the outside of the growing rudiment 
into the kidney. Use of a Cre allele expressed from the endogenous Pax8 locus (Bouchard et 
al., 2004) resulted in scattered eYFP-positive cells in the E11.5 metanephric mesenchyme and 
a strong signal in the condensed mesenchyme and in the ureteric bud (Fig. 1B and Supp. Movie 
1B). During the subsequent culture, the lineage trace was found extensively in the newly 
formed condensates, the resulting nephrons and the ureteric bud. The time-lapse data illustrate 
how some labelled cells from the cap mesenchyme are left behind by the growing bud, increase 
in number, and condense to form a nephron. Since Wt1 is not expressed in the ureteric bud, the 
activity of Pax8+/Cre there does not affect the analysis presented here. Finally we used a CreGFP 
fusion construct knocked into the endogenous Wnt4 locus (Shan et al., 2010). As described, 
this driver becomes active in the pre-tubular aggregates and subsequently traces the complete 
nephron (Fig. 1C and Supp. Movie 1C). The GFP signal from the Wnt4CreGFP allele is barely 
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detectable on the time-lapse system (Shan et al., 2010 and data not shown), therefore all signal 
comes from the eYFP reporter.  
 Before crossing our Wt1 conditional allele (Martinez-Estrada et al., 2010) to the three 
Cre drivers, we confirmed that it is a conditional version of the conventional Wt1 knockout 
(Kreidberg et al., 1993) by crossing it to a germline Cre deleter strain expressing a CAGGs-
driven Cre transgene to generate heterozygous Wt1+/- mice. Homozygosity for this recombined 
allele was found to be an exact phenocopy of the conventional knockout, including the kidney, 
gonad, epicardium and diaphragm phenotypes (Supp. Fig. 1 and data not shown). Next, the 
Wt1 conditional allele was crossed to each of the three Cre drivers we had characterized above. 
Cre-positive (all three drivers) / Wt1 conditional heterozygous mice were viable and healthy 
(data not shown). With one exception (see below), the Cre-positive Wt1 conditional 
homozygous genotypes were not compatible with postnatal life. Embryos developed up to birth 
and were macroscopically normal (though slightly smaller than control littermates in the case 
of Nes-Cre Wt1co/co embryos), but died immediately after birth. As there is overlap between the 
activities of the Cre drivers and Wt1 outside the kidney, we used Optical Projection 
Tomography (Sharpe et al., 2002) to generate 3D reconstructions of E16.5 whole embryos. The 
complete OPT image sets (3D volumes) with a number of visualisations and movies are 
provided on the eMouseAtlas (Richardson et al., 2014) community pages at 
http://testwww.emouseatlas.org/emap/community/submission000001/hohenstein.html. The 
OPT images can be viewed in virtual section mode using the IIP3D image viewer (Husz et al., 
2012). 
We analysed the kidneys of E18.5 embryos in more detail (Figure 2A-D). As described 
before, in Nes-Cre Wt1co/co kidneys nephron development is disturbed at the MET stage leading 
to an expansion of the mesenchyme. Condensation and epithelialisation are severely affected, 
except for regions where Wt1 is not lost due to incomplete function of Nes-Cre (Essafi et al., 
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2011). In contrast, in Wnt4+/CreGFP Wt1co/co kidneys MET is possible as there is condensation, 
epithelialisation and early tubulogenesis (comma and S-shaped body stages), albeit at reduced 
levels. Expanded mesenchyme can be found in these kidneys as well, although 
glomerulogenesis and tubular maturation are absent. Pax8+/Cre Wt1co/co kidneys showed normal 
levels of condensation, epithelialisation and early tubulogenesis, but tubule maturation and 
glomerulogenesis are still absent. As was the case for the Nes-Cre Wt1co/co kidneys (Essafi et 
al., 2011), no differences in proliferation or apoptosis were found in the other two models (data 
not shown); the ‘escaping nephrons’ that develop completely normally but are still Wt1-
positive in the Nes-Cre driven mutant were not found in the other mutants either (data not 
shown). 
 We serendipitously identified one surviving Nes-Cre Wt1co/co mouse. This mouse 
developed a lump on its back at 25 weeks of age. Macroscopic analysis identified a large tissue 
mass in place of the right kidney (Figure 2E, F). Microscopic analysis identified this as a 
Wilms’ tumour (Figure 2G). The left kidney was relatively normal and contained many more 
escaping nephrons than usual (data not shown). We assume this left kidney provided sufficient 
renal function for this animal to survive, thereby giving the right kidney time to develop this 
tumour. 
 
Histological phenotyping of Wt1 mutants through genome-wide expression analysis. 
It has previously been shown that many genes are expressed in more than one 
developmental stage in the kidney (Brunskill et al., 2008). The identification of true anchor 
genes, which are uniquely expressed in just one specific cell type  or developmental stage, can 
be challenging, especially for the stages immediately before and after the MET, on which we 
focused our analysis (Thiagarajan et al., 2011). This limits the usefulness of analysing 
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individual genes to describe developmental phenotypes like the ones found here. Instead, we 
hypothesized that global expression patterns could provide means to describe complex 
phenotypes. To test this we generated microarray data from E18.5 total kidney RNA of the 
three mutant genotypes. We first compared each Cre+ Wt1co/co dataset to the corresponding 
Cre+-only data to identify differentially expressed genes for each mutant and correct for 
changes due to expression of the Cre or, in the case of Wnt4 and Pax8-driven Cre alleles, 
haploinsufficiency of the driver gene (Supp. Fig. 2 and Supp. Table 1). Comparison of 
increased and decreased genes for each of the mutants showed 84 increased and 159 decreased 
genes were shared between two or three mutants, with larger numbers of genes being uniquely 
differentially expressed in individual mutants (Fig. 3A). To identify candidate direct targets for 
Wt1 in the differentially expressed genes we compared the gene lists to Wt1 ChIP-seq data 
from a recently published study on E18.5 mouse kidneys (Motamedi et al., 2014) and identified 
multiple genes in each differential geneset that showed in vivo binding of Wt1 to their genomic 
loci (Supp. Table 2). Though experimental confirmation of these potential target genes falls 
outside the scope of this work (see Discussion), potentially important kidney developmental 
and disease genes can be identified this way. For instance, Receptor-type tyrosine-protein 
phosphatase O (Ptpro) is decreased in all three mutants and has direct binding of Wt1 to its 
genomic locus, making it a strong candidate for direct control by Wt1. This gene has previously 
been shown to be mutated in childhood-onset nephrotic syndrome (Ozaltin et al., 2011) and is 
a candidate gene for the HIVAN4 nephropathy-susceptibility locus (Prakash et al., 2011).  
We reasoned that decreased genes in these differential datasets would represent genes 
from kidney developmental stages that are not reached in the mutants due to the failure of 
maturation, whereas increased genes could be either enrichment of the genes expressed at the 
stage of the differentiation block or ectopically expressed genes. We compared our differential 
gene sets to the kidney compartment-specific genome-wide expression patterns  as they are 
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being generated (via microarray and RNA-seq analysis of micro-dissected and FACS-sorted 
cell populations) and made available by the GUDMAP project (Harding et al., 2011). These 
data provide expression signatures of each compartment in the developing kidney, even if the 
genes that make up this signature are not unique for this compartment. Note that in this 
approach, we use differentially expressed genes solely as a signature for the stage where 
development is blocked, and that this is independent from whether or not the differential genes 
are direct targets for control by Wt1. Geneset enrichment analysis using the ToppCluster tool 
(Kaimal et al., 2010), which analyses enrichment for each of these compartment-specific 
signatures (as well as to other biological datasets such as GO terms and phenotypic data 
sources), was used to further analyse the stage of developmental block in the different mutants. 
We hypothesized that enrichment for certain compartment-specific signatures would be 
indicative of a developmental block at that stage or close to that stage.  The increased genes in 
the three mutants significantly overlapped with many genes from early developmental stages 
from the GUDMAP data (Fig. 3B). These include different cap mesenchyme datasets 
(including E15.5 and early postnatal), E11.5 metanephric mesenchyme and E15.5 pelvic 
mesenchyme. This demonstrates that the three mutants expressed sets of genes that are 
normally (in wild-type kidneys) found in these cell types / developmental stages. More 
informative were the enrichment patterns that were found for one or two of the mutants, as they 
illustrated the order in which the phenotypes arise. For instance, enrichment for genes normally 
expressed in the S-shaped body was exclusively found in the Pax8+/Cre Wt1co/co mutant kidneys. 
This is indeed the only one of the three mutants that can reach this developmental stage. 
Enrichment for genes normally found in the stage III and IV renal corpuscle (as defined on 
http://gudmap.org/Organ_Summaries/component_summary.php?componentID=10) can be 
recognized in the Wnt4+/CreGFP and Pax8+/Cre driven mutants. The Nes-Cre and Pax8+/Cre Wt1co/co 
mutants are enriched for genes normally expressed in the Ren1-positive cells from the adult 
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juxtaglomerular apparatus, suggesting these cells maintain a relative primitive character. The 
enrichment for genes normally found in the adult mesangium in the Pax8+/Cre driven mutants 
suggests an origin around the stage these mutants arrest for this cell type. For the decreased 
genes, enrichment is strongest for all late developmental and adult cell types in all three mutants 
(Figure 3C), consistent with the fact that these stages are not reached in any of the models.  
 
Functional phenotyping of Wt1 mutants through genome-wide expression analysis. 
Geneset enrichment analysis of the differentially expressed genes performed using 
ToppGene (Chen et al., 2009) confirmed  diverse effects of the three mutants (Supp. Table 3). 
For instance, for the increased genes the most significant ‘Molecular Function’ GO term was 
‘receptor binding’ for the Nes-Cre Wt1 conditionals (44 genes, p=9.24E-09), ‘platelet-derived 
growth factor binding’ (3 genes, p=2.20E-04) for the Wnt4-CreGFP Wt1 conditionals and 
‘phosphoprotein phosphatase activity’ for the Pax8+/Cre driven mutants (9 genes, p=5.33E-04). 
For the GO term ‘Cellular Component’ the ‘extracellular region part’ was the most significant 
for the Nes-Cre Wt1co/co (42 genes, p=2.24E-08), ‘cytosolic ribosomal subunit’ for Wnt4+/CreGFP 
Wt1co/co (5 genes, p=4.11E-05) and ‘basal plasma membrane’ for the Pax8+/Cre Wt1co/co mutants 
(5 genes, 1.11E-04). Correspondingly, the most enriched gene families in the increased genes 
were ‘Claudins’ for the Nes-Cre driven mutants (3 genes, p=3.18E-04), ‘ribosomal proteins’ 
for the Wnt4+/CreGFP (5 genes, p=3.42E-04) and again ‘Claudins’ for the Pax8+/Cre Wt1co/co 
mutants (3 genes, p=5.33E-04). For the decreased genes ‘Molecular Function’ GO terms were 
most enriched for ‘symporter activity’ for the Nes-Cre Wt1co/co (9 genes, p=9.41E-07), ‘cofactor 
binding’ for Wnt4+/CreGFP Wt1co/co (37 genes, p=1.84E-17) and ‘transporter activity’ for 
Pax8+/Cre Wt1co/co mutants (37 genes, p=3.23E-09). Most significant ‘Cellular Component’ GO 
terms for the decreased genes were ‘apical part of cell’ for the Nes-Cre driven mutants (13 
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genes, p=6.51E-06) and ‘brush border’ for both the Wnt4+/CreGFP (20 genes, p=1.96E-16) and 
Pax8+/Cre (11 genes, p=2.39E-10) driven mutants. 
To describe the biological consequences of the different developmental blocks in more 
detail we analysed the ‘Biological Process’ GO terms and ‘Human and Mouse Phenotypes’ 
terms using ToppCluster. Increased genes (Figure 3D) function in positive regulation of cell 
proliferation, circulatory system development and renal system development, and are involved 
in increased metanephric mesenchyme apoptosis and absent kidneys for all three mutants. 
Increased genes shared by Nes-Cre and Pax8+/Cre driven mutants were involved in the negative 
regulation of cell death, response to hypoxia and positive regulation of cell migration. Increased 
genes in the Nes-Cre Wt1co/co kidneys were uniquely involved in nephron development, kidney 
size and positive regulation of epithelial to mesenchymal transition, whereas phenotypes 
uniquely linked to the Pax8+/Cre Wt1co/co mutants include glomerular crescent and abnormal 
glomerular capillary morphology. An apparent up-regulation of the EMT in the Nes-Cre 
Wt1co/co is in accordance with the block in the opposite MET we found in the histological 
examination of this mutant (Fig. 1B). Decreased genes (Figure 3E) in all three mutants showed 
a strong correlation with normal kidney function and physiology and glomerular development. 
More specific functions and phenotypes were found shared between two mutants or uniquely 
for single mutants, such as ‘regeneration’ for the Nes-Cre driven mutants, epithelial cell 
differentiation for the Pax8+/Cre Wt1co/co mutants (in accordance with this being the only mutant 
capable of undergoing the normal renal MET) and renal salt wasting shared between the Nes-
Cre and Wnt4+/CreGFP mutants. 
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 Confirmation of the differential srenal phenotypes. 
 The combined data showed that Nes-Cre driven loss of Wt1 results in disturbance of the 
MET while Pax8-Cre Wt1co/co reaches a developmental block after the MET but before tubule 
maturation and glomerulogenesis. The Wnt4+/CreGFP Wt1co/co appears to be a combination of 
both; the reduced epithelialisation suggests that in some cases the MET is still disturbed, 
whereas in cases where the MET was successful the resulting nephrons were blocked at the 
same stage as observed in the Pax8+/Cre Wt1co/co mutants. We therefore limited a more detailed 
phenotypic analysis to the Nes-Cre Wt1co/co and Pax8+/Cre phenotypes. We first analysed the 
nephrogenic progress in control and mutant kidneys on time-lapse using a Wt1GFP knock-in 
allele (Hosen et al., 2007). This reporter allele lacks Wt1 exon 1, just as the conventional 
knockout and our conditional allele (after Cre activity). We crossed this allele to the Wt1co 
model; in this combination the reporter allele will remain active in the absence of the wild-type 
allele and can therefore be used to identify, follow and isolate the mutant cells. In control 
Wt1co/GFP kidneys the brightfield data showed clearly how condensed mesenchymes are formed 
around the tips of the growing ureteric bud, which subsequently epithelialize and form mature 
nephrons. The GFP signal (identifying Wt1 expression) was weak but detectable in the 
metanephric mesenchyme, increased in the cap-mesenchyme, further increased as the tubular 
stages are reached, with strong signal only remaining in the podocytes of the mature glomeruli 
(Fig 4A and Supp. movie 2) thereby closely mimicking the known Wt1 expression pattern. 
Mutant Nes-Cre Wt1co/GFP kidneys showed the increase in GFP signal in the cap-mesenchyme 
but no further development (except in some escaping nephrons as discussed before), whereas 
the brightfield data showed a corresponding lack of epithelialized structures  (Fig. 4B and Supp. 
movie 2). The brightfield signal for Pax8+/Cre Wt1co/co kidneys showed the formation of 
condensed mesenchymes and some epithelialisation and nephron formation, accompanied by 
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an increase in GFP signal in the cap-mesenchyme and a slight further increase as the early 
nephrons form; however complete maturation of the signal as seen in the controls was missing 
(Fig. 4C and Supp. Movie 2). The phenotypes found in this time-lapse analysis therefore 
confirm the histological and microarray analysis of the mutants.  
The phenotypes observed in the E18.5 H&E stained sections and in the time-lapse 
analysis were analysed using antibody staining of kidney organ cultures (Fig. 5). Antibody 
staining for E-cadherin and Wt1 of control kidneys (Wt1co/co) showed the expected E-cadherin 
staining in ureteric bud and developing tubules, the latter confirming the normal MET; Wt1 
staining was found in the cap mesenchyme as well as different stages of tubulogenesis and 
glomerulogenesis (Fig. 5A). Nes-Cre mediated loss of Wt1 resulted in an almost complete loss 
of WT1 staining in the mesenchyme, while the almost complete absence of E-cadherin positive 
nephrons confirmed the disturbed MET (Fig. 5B). A few escaping nephrons with increased 
Wt1 staining indicative of mature podocytes and E-cadherin in the corresponding tubules could 
easily be identified. In contrast, in Pax8+/Cre Wt1co/co kidneys, there was a clear increase in Wt1 
expression in the cap-mesenchyme as expected for the later loss of Wt1 in this mutant. E-
cadherin staining confirmed early stages of tubulogenesis taking place, but Wt1 was lost by the 
time this stage was reached (Fig. 5C). Using antibodies against Pax8 as a marker for nephron 
induction and pan-Cytokeratin as an epithelial marker the same phenotypes were found (Fig. 
5D-F). We looked in more detail at the development of the proximal tubules using antibodies 
against Megalin. Staining for this marker was found in control and Nes-Cre Wt1co/co samples 
(Fig. 5G-J) and as expected co-staining with Wt1 and Megalin antibodies confirmed that in the 
mutants Megalin was only found in the escaping nephrons (Fig. 5K-N). In controls, Megalin is 
found in proximal nephron segments where E-cadherin expression is low. Pax8+/Cre Wt1co/co 
kidneys showed expression of Megalin and E-cadherin intermingling, suggesting a patterning 
defect (Fig. 5O,P).  
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
Ac
ce
pt
ed
 m
an
us
cr
ip
t
 
 
 
 
 
Wilms’ tumour development is in many cases directly linked to a loss of control of the 
nephrogenic progenitor cells (Hohenstein et al., 2015). In murine embryonic kidneys Six2 is 
considered a marker for these progenitor cells (Kobayashi et al., 2008), whereas in human 
embryonic kidneys NCAM1 was identified as nephron progenitor marker (Harari-Steinberg et 
al., 2013). We therefore stained the Nes-Cre and Pax8+/Cre driven mutants for these markers 
(Fig. 6). To identify the Wt1-mutant cells we included the Wt1GFP allele in this. As shown before 
(Harari-Steinberg et al., 2013), the expression of Ncam1 overlaps with Six2 expression, but is 
also found in the epithelialized nephron, especially towards the proximal end. In Nes-Cre 
Wt1co/GFP kidneys there appears to be a decrease in the number of Six2+ cells, but this is likely 
linked to the smaller size of these kidneys. However, the Six2+ compartment is more 
disorganized and in some places the signal extends beyond the normal cap mesenchyme that 
sits closely around the ureteric tip. In addition there are ectopically located Wt1GFP-positive 
cells in the centre of the kidney, most likely corresponding to the extended mesenchyme we 
identified in the histological analysis (Fig. 2B). These cells are negative for Six2 and Ncam1, 
suggesting they are at a stage preceding the progenitor stage or have differentiated to a 
completely different fate. We also noted that whereas in the controls there are no Wt1GFP 
positive cells outside the Six2+/Ncam1+ cap mesenchyme, in the Nes-Cre Wt1co/GFP kidneys 
such cells are widespread. Finally, the GFP signal in the cap mesenchyme and the region 
around it is higher in the Nes-Cre driven mutants than in the controls.  
 In comparison, the Pax8+/Cre Wt1co/GFP mutants do not show the GFP signal in the centre 
of the kidney, consistent with the absence of the extended mesenchyme in these mutants (Fig. 
2D), nor do they show the signal outside the cap mesenchyme. Consistent with the histological 
data, there are Six2-/Ncam1+ signals that show an increase in the GFP signal, confirming these 
mutants can reach the post-MET / early tubulogenesis stage but cannot form glomeruli. The 
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Six2+ cap mesenchyme is normal, in line with the later developmental block compared to the 
Nes-Cre Wt1co/GFP mutants. 
We noticed that in organ cultures from both mutants the ureteric buds showed an 
aberrant branching pattern. Whereas control kidneys show the expected bifurcation and 
occasional trifurcation (Watanabe and Costantini, 2004), the mutant ureteric buds showed 
many more branches apparently coming from the same node. To describe this phenotype in 
more detail we analysed the dynamics of the ureteric bud branching using time-lapse imaging. 
For Nes-Cre Wt1co/co kidneys we could use the brightfield signal, but in control kidneys the 
development of nephrons rapidly obscures the ureteric bud, so for this we used Hoxb7-Cre (Yu 
et al., 2002) to activate the eYFP reporter specifically in the ureteric bud and analysed the 
fluorescent signal. These data showed that the phenotype does not result from one tip giving 
rise to more than two branches. Instead, the branching develops relatively normal for the first 
three days, after which branches stop elongating and bifurcating further but contract while the 
nodes move into each other. This was confirmed by quantifying branch length, width and 
angles in mutant and control kidneys (Fig 7A; Supp. Fig. 3).   
As no Wt1 expression has been reported in the ureteric bud, the observation of a 
branching phenotype in these mutants was unexpected. Although the Pax8+/Cre driver is active 
in the ureteric bud, the Nes-Cre appears not to be active there (Fig. 1), making low-level (but 
functional) Wt1 expression in the ureteric bud an unlikely cause of the phenotype. To fully 
exclude this possibility we crossed the Wt1 conditional knockout with the Hoxb7-Cre driver to 
knockout Wt1 only in the ureteric bud. Hoxb7-Cre Wt1co/co mice were born in the expected 
ratio, and were viable and healthy (data not shown). Hoxb7-Cre Wt1co/co show a normal 
branching pattern in kidney organ culture (Fig. 7B). This shows that the disturbed branching 
of the ureteric bud is caused by loss of Wt1 in the mesenchymal compartment. We sought to 
rescue the branching phenotype using recombination experiments between Wt1 mutant ureteric 
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buds with wild-type mesenchymes (Fig. 7C). Mechanical dissection of the mutant ureteric bud 
followed by recombination with wild-type mesenchymes and subsequent in vitro culture still 
showed the branching defect. However, this mechanical dissection leaves a thin layer of 
mesenchymal cells (in this case Wt1-mutant) attached to the ureteric bud. If these cells were 
removed using trypsin, the wild-type mesenchyme rescued the branching phenotype (Fig. 7C). 
This not only confirms that the branching phenotype is caused by loss of Wt1 in the 
mesenchymal compartment, it identifies the mesenchymal cells directly lining the ureteric bud 
as the cells from which the phenotype originates.       
 
Differential Wt1 phenotypes correspond to different Wilms’ tumour sub-groups. 
 As the Nes-Cre and Pax8+/Cre drivers result in Wt1 loss immediately before and after 
the nephron MET respectively, we reasoned that if disturbance of the MET is indeed important 
in the formation of Wilms’ tumours (Hastie, 1994), characteristics of the tumours might already 
be found in these E18.5 mutant kidneys. If so, it would suggest these changes are the direct 
effects of WT1 loss rather than events selected for during, or bystander effects of, the 
tumourigenic process. We compared a published microarray dataset of WT1-mutant and WT1-
wild-type tumours (Corbin et al., 2009) to the Nes-Cre Wt1 conditional and Pax8+/Cre Wt1 
conditional datasets (Fig. 8A; Supp. Table 3). For the decreased genes the biggest overlap was 
found in the intersection between the Nes-Cre Wt1 conditional and both sets of Wilms’ tumour 
datasets (9 genes) or the Pax8+/Cre Wt1 conditional and both tumour sets (18 genes). We used 
the ToppGene analysis tool to identify significant functional enrichment in these gene sets. 
Significant enrichments for both sets were indicative of disturbed kidney function (Supp. table 
3). For the increased genes, the highest overlap was found between the Nes-Cre Wt1 conditional 
increased genes and the WT1-mutant Wilms’ tumour increased genes (13 genes, Figure 4A). 
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These genes were enriched for muscle-related GO-terms (Supp. table 3). The ‘molecular 
function’ significant hits included ‘myosin binding’ (p=3.15E-6), ‘troponin T binding’ 
(p=2.79E-6) and ‘structural constituent of muscle’ (p=3.75E-4). Significant hits for the 
‘biological process’ GO-term included only muscle-related terms, like ‘muscle filament 
sliding’ (p=1.00E-13), muscle organ development (p=9.59E-5) and ‘muscle contraction’ 
(p=2.46E-8). Finally, the ‘cellular component’ GO-term also identified the ‘muscle’ theme 
with significant hits including ‘sarcomere’ (p=9.30E-12), ‘striated muscle thin filament’ (p-
=2.46E-7) and ‘troponin complex’ (p=1.23E-5). 
 We analysed the increased gene sets in more detail at the functional level using 
ToppCluster for ‘biological process’ GO-terms. Enriched terms were colour coded for different 
categories to enable the visual recognition of patterns in the datasets (Figure 8B). In accordance 
with the comparison at the gene level, muscle-related terms (red nodes) are strongly clustering 
with the Nes-Cre Wt1 conditional and / or WT1-mutant Wilms’ tumours samples. Within these 
datasets, a ‘developmental cascade’ can be recognized; terms uniquely enriched in the Nes-Cre 
Wt1co/co samples are related to muscle cell proliferation and differentiation, in the overlap 
between the Nes-Cre Wt1co/co and WT1-mutant tumours for filament assembly and uniquely in 
the WT1-mutant tumours for muscle function-related terms, such as contraction and relaxation, 
as well as differentiation into specific muscle types. GO-terms related to bone and cartilage 
processes, blue nodes, do not show such dataset-specific enrichment clustering. Apoptosis-
related GO-term enrichment (yellow nodes) are spread over the four datasets as well, but there 
is a remarkable shift from enrichment of pro-apoptotic GO-terms for the two mouse samples 
to negative regulation of apoptosis in the tumour samples. Enrichment for epigenetic modifier 
functions (green nodes), especially H3K4 and H3K9 methylation, is uniquely found in the WT1 
wild-type tumours. Cell cycle / cell division enrichment (orange nodes) is also biased towards 
the WT1 wild-type tumours, though not exclusively. Notably, whereas all samples show 
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enrichment for some cell division-related GO-terms, the WT1 wild-type tumours show 
enrichment for regulation of every possible aspect of cell cycle control, including every phase 
transition, spindle functions, checkpoints, DNA replication and chromosome separation. 
Finally, GO-terms related to kidney development (grey nodes) are found for the Pax8+/Cre 
Wt1co/co kidneys and the WT1 wild-type Wilms’ tumours but not in the Nes-Cre Wt1co/co and 
WT1-mutant Wilms’ tumour samples, consistent with an early, pre-MET, origin of these 
tumours.   
 The Nes-Cre Wt1co/co kidneys showed an expression signature consistent with early 
muscle differentiation, but an increased differentiation towards bone and cartilage could be 
recognized in both mutants (Fig 8B). We therefore analysed these kidneys with histological 
stains commonly used to detect bone (Alizarin Red) and cartilage (Alcian Blue). Alzarin Red 
could be detected throughout both mutant and control kidneys (Fig 8C), this was much less 
intense than seen in developing bone in the same sections (not shown). We do not know if the 
signal we see in the kidneys is aspecific or indicates the presence of calcium throughout the 
control and mutant kidneys. Alcian Blue was not found in the control kidneys, but seen in the 
expanded mesenchyme in the Nes-Cre Wt1co/co throughout the nephrogenic zone and the 
medulla (Fig 8C). Some Alcian Blue staining was found in the Pax8+/Cre Wt1co/co mutant 
kidneys but only in the medulla and not throughout the nephrogenic zone. 
These data demonstrate that the primary results of pre-MET Wt1 loss, as modelled by 
the Nes-Cre Wt1co/co mice, are the earliest event in the development of WT1-mutant Wilms’ 
tumours. The WT1-wild-type tumours show a closer phenotypic resemblance to the effects of 
the post-MET Pax8+/Cre-mediated loss of Wt1, even though the initiating genetic event will be 
different for these tumours. Separating the two types of Wilms’ tumours through phenotypic 
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overlap with these two mouse models identifies clear biological differences between the 
tumour types.      
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Discussion. 
Wilms’ tumour is an archetypal example of a tumour that is the direct effect of 
disturbance of normal development. The developmental origin provides an important platform 
to describe the earliest events of the tumourigenic process. Though different groups of Wilms’ 
tumours have been described, the genetically best-defined group still remains the 15-20% of 
cases that are caused by biallelic loss of the WT1 tumour suppressor gene. To understand how 
loss of WT1 causes Wilms’ tumours, a better understanding of its role in normal kidney 
development is essential. To this end, we have used a conditional Wt1 knockout mouse model 
and different Cre drivers, thereby focussing on the MET at the onset of nephrogenesis. 
 
Wt1 as ‘master facilitator’ of kidney development. 
We have previously shown that Wt1 is essential for renal nephron formation (Davies et 
al., 2004) through direct activation of Wnt4 (Essafi et al., 2011). Here we provide a detailed 
study of the Nes-Cre Wt1co/co phenotype using time-lapse imaging, antibody staining and 
genome-wide expression analysis. The combination of the lack of epithelialization and 
extended mesenchyme in E18.5 embryos, the ex vivo time-lapse phenotype of the Nes-Cre 
Wt1co/co, the antibody staining of organ cultures (E-cadherin, Pax8, pan-cytokeratin and 
Megalin, Six2, Ncam1), the gene enrichment analysis on the microarray data (all this study) 
and the loss of direct activation of Wnt4 (Essafi et al., 2011) leave no doubt that this mutant 
demonstrates the direct role of Wt1 in the control of the nephron MET. Using the Pax8+/Cre 
driver, we show that loss of Wt1 immediately after the MET leads to a block in nephrogenesis 
after tubulogenesis is initiated but before tubule maturation and glomerulogenesis takes place. 
Antibody staining for E-cadherin and Megalin showed that although nephrons start to form in 
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Pax8+/Cre Wt1co/co mutants, the developing nephrons lose their proximal-distal patterning with 
both markers co-expressed along the axis. 
Wt1 is expressed at many stages of kidney development of mouse (Armstrong et al., 
1993) and human (Pritchard-Jones et al., 1990) nephrogenesis, and combined with previously 
published data the different models used here show it might have different, albeit essential, 
functions at all these stages (Ozdemir and Hohenstein, 2013). In the intermediate mesoderm 
Wt1 has a pro-survival role, demonstrated using the conventional Wt1 knockout (Kreidberg et 
al., 1993). Next, Wt1 controls the MET leading to nephron formation (this study and Essafi et 
al., 2011). Post-MET Wt1 is essential for tubule maturation and glomerulogenesis (this study). 
Wt1 is essential for podocyte function as shown by the development of glomerular sclerosis in 
mice heterozygous for the conventional knockout (Guo et al., 2002; Menke et al., 2003) and 
Wt1+/R394W (Gao et al., 2004; Ratelade et al., 2010) alleles. As these mutations are present from 
early in development a developmental cause of these phenotypes cannot be excluded. However, 
the renal phenotype in our adult body-wide conditional Wt1 knockout model confirms Wt1 is 
essential for podocyte function and maintenance (Chau et al., 2011).  
Given the absence of Wt1 expression in the ureteric bud the branching phenotype was 
unexpected. However, the combination of the lack of phenotype in the Hoxb7-Cre Wt1co/co 
mutants and the recombination experiments undoubtedly place the origin of this phenotype in 
the mesenchymal-derived component of the developing kidney. Our time-lapse analysis 
indicated that the phenotype is the result of dynamic remodelling of an apparent normal 
branched ureteric bud. We recently presented a ‘node retraction’ mechanism similar to this but 
at a slightly later time point through which early Y-shaped branches convert to parallel V-
shaped branches (Lindstrom et al., 2015). The data presented here could implicate Wt1 in the 
cells lining the ureteric bud in controlling this morphological change.   
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We previously showed how Wt1 can control the chromatin state of a complete target 
locus through the ‘chromatin flip-flop’ mechanism and suggested it does this to control the 
accessibility of its target loci to other signals and pathways (Essafi et al., 2011). Based on the 
accumulating functions of Wt1 in different stages of kidney development as shown here we 
extend this to propose a ‘master facilitator’ role for Wt1. Using the chromatin flip-flop, Wt1 
could oversee correct development at the chromatin level by allowing some genes to respond 
to specific signals but preventing other genes to respond to these signals at a given 
developmental stage. At a later stage though, Wt1 could allow these genes to respond to these 
signals, if it has altered the chromatin state to a submissive state via the flip-flop mechanism. 
This model would explain why loss of Wt1 would lead to a block in nephron development at 
different stages. As shown for the control of Wnt4 expression, loss of Wt1 locks the target locus 
at the chromatin level and expression cannot be induced, even if a gene-specific activation 
signal, like a canonical Wnt signal (Karner et al., 2011; Park et al., 2012), would still be present. 
Vice versa, this model would predict that Wt1 activity is not instructive, even if it would open 
up a locus the expression of the locus would still be depending on another signal. This way, 
Wt1 facilitates correct development, making the gene necessary but not sufficient.   
 The differentially expressed genes in our mutant models will be a mixture of direct and 
indirect Wt1 targets, as well as changes that reflect the stage where nephron development was 
blocked. We focused our analysis on the latter and showed that comparing genome-wide 
differential gene sets and cell type-specific expression signatures from the GUDMAP projects 
is an efficient way of identifying and describing the developmental blocks in the different 
mutants. Identifying the direct Wt1 targets in the differential gene sets and describing the exact 
role of Wt1 is far from straight-forward and falls outside the scope of the current work. Firstly, 
Wt1 controls gene expression of target genes in a dichotomous manner, the same target gene 
can be activated in one tissue and repressed in another, or even in different developmental 
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stages of the same tissue (Essafi et al., 2011). The repetitive nature of nephron induction and 
the expression of Wt1 in different stages of nephron development means that E18.5 samples, 
as used here, will consist of cell types where WT1 can activate and repress the same targets, 
and will contain cell types where Wt1 is already lost and cell types where it is still present. For 
this reason, comparing differential genes from our analysis to E18.5 Wt1 ChIP-seq data as 
recently published (Motamedi et al., 2014) does not provide conclusive data on targets of Wt1 
in specific cell types that could explain the phenotypes described here, nor could the mode of 
action of Wt1 (activating or repressing) in these phenotypes be deduced from it. We compared 
our differential genes to the top 1000 peaks from Motamedi et al (2014) and identified several 
strong candidates for direct Wt1 targets in our data (Supp. Table 2), though conservative use 
of our array data as well as the ChIP-seq data means this list is far from complete. Confirmation 
and correct interpretation of these candidates would require means of specifically isolating the 
mutant cells from the complex samples described above and is currently not possible. 
        
Wt1 loss and the origins of Wilms’ tumours. 
A number of microarray studies have described that Wilms’ tumours resemble cells 
from  the developing kidney around the MET stage, and found a clear distinction between the 
WT1/β-catenin mutant and wild-type subsets of tumours (Corbin et al., 2009; Dekel et al., 2006; 
Fukuzawa et al., 2009; Gadd et al., 2012; Li et al., 2002; Li et al., 2004). Some of these studies 
have proposed a different developmental origin for these two subgroups based on expression 
analysis of established tumours (Fukuzawa et al., 2009; Gadd et al., 2012). Gadd et al analysed 
224 tumours and proposed that WT1/β-catenin mutant tumours originate from the intermediate 
mesoderm, whereas the WT1/β-catenin wild-type tumours would originate from the 
metanephric mesenchyme.  Experimental confirmation of this has so far been lacking. The only 
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existing mouse model for WT1-deficient Wilms’ tumours is based on a combination of 
conditional Wt1 loss with activation of Igf2 (through loss of H19; Hu et al., 2011). Although 
tumours with this combination of genetic aberrations can be found in patients, phenotypically 
they are closer to the WT1-wild-type subset than the WT1/β-catenin mutant tumours (Gadd et 
al., 2012). Moreover, this mouse model is driven by a low dose tamoxifen-controlled 
ubiquitous activation of Cre, making it difficult to determine the exact developmental stage 
these tumours arose from.  
Given the different development stages where nephron development in our mutant 
models is blocked, we decided to compare the genome-wide expression patterns of the mice to 
the two main groups of human Wilms’ tumour (WT1-mutant and WT1 wild-type). This 
comparison showed a close resemblance between the Nes-Cre Wt1co mutants and the WT1-
mutant tumours, especially with respect to the ectopic muscle development signature, whereas 
the phenotype in the Pax8+/Cre Wt1co mutant kidneys more resembled the one found in WT1 
wild-type Wilms’ tumours. This would suggest the latter originates in a developmental block 
at the same stage as the Pax8+/Cre-driven mutants even if the causative mutation is different and 
currently unknown. Whereas our data provides experimental support for the model put forward 
by Fukuzawa et al (2009) and Gadd et al (2012) on different developmental origins of these 
two groups of tumours, our data suggests different developmental stages than deduced by Gadd 
et al from the expression profile of the tumours. The authors suggested an intermediate 
mesoderm origin for the WT1-mutant tumours and a metanephric mesenchyme origin for the 
WT1 wild-type cases. If the Nes-Cre Wt1co phenotype models the first events in the 
development of WT1-mutant tumours as we propose based on the block before the MET stage, 
the expanded mesenchyme and the muscle differentiation signature, the stage of origin of WT1-
mutant tumours must be later than the intermediate mesoderm. It is clear from the conventional 
knockout that loss of Wt1 at that stage results in an apoptotic response rather than 
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developmental block (Kreidberg et al., 1993). We serendipitously found a single surviving Nes-
Cre Wt1co/co mouse that developed a stromal predominant Wilms’ tumour at 5 months of age 
in the right kidney. As this mouse had a bigger than usual number of escaping nephrons in the 
left kidney, we assume this kidney kept the mouse alive to allow the development of the further 
tumour from the right kidney. We do not present this single case as a mouse model for Wilms’ 
tumours, but it does confirm that an MET block can give rise to these tumours. Equally, the 
post-MET / early tubulogenesis block found in the Pax8+/Cre Wt1co kidneys more resembles the 
epithelial nature of WT1 wild-type tumours. So although order of developmental blocks in our 
data is the same as proposed by Gadd et al, the exact stages have shifted. Interestingly, a recent 
analysis of Wilms’ tumour cancer stem cells (CSCs) has shown that these cells de-differentiate 
to an early developmental stage to form the bulk of the tumour (Shukrun et al., 2014) indicating 
the histology (and by extension the expression pattern) of a Wilms’ tumour does not necessarily 
represent the stage of origin of the tumour.  
Our analysis of Six2 and Ncam1 expression showed that the expanded mesenchyme we 
observe in the histological analysis of the Nes-Cre driven Wt1 mutants is negative for both 
these nephron progenitor cell markers. This can be explained by either this mesenchyme 
originating from the nephron progenitor cells but differentiating to a completely different cell 
fate, or the expanded mesenchyme originating from a stage preceding the nephron progenitor 
stage. At present we cannot exclude the former, but the latter would be in full accordance with 
the Wt1-mutant tumours originating from an earlier developmental stage. This expanded 
mesenchyme also stains positive for Alcian Blue and these mutants show an early muscle 
development gene signature. Although E18.5 Nes-Cre Wt1co kidneys do not show 
histologically recognizable muscle tissue, the recognition of an early muscle differentiation 
signature just a week after loss of Wt1 could suggest this is a direct effect of this loss that does 
not require the activating mutations in CTNNB1 that are found in the majority of these tumours. 
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It could suggest an inhibiting role for Wt1 on muscle development. The literature on this is 
contradictory. One study described that overexpression of Wt1 in myoblast cells did indeed 
inhibit their differentiation (Miyagawa et al., 1998) but a second study could not confirm this 
(Tiffin et al., 2003). The data presented here clearly justifies more work on this. We propose 
that prior to the condensation of the mesenchyme to form the cap the kidney cells still have the 
potential to form other mesodermal tissues, and Wt1 is stopping them from doing so using the 
same chromatin flip-flop and master facilitator mechanisms as discussed above. At later stages 
the cells become committed to a renal fate, and subsequently Wilms’ tumours arising after this 
step (the WT1 wild-type tumours) cannot form the ectopic tissues found in the WT1–mutant 
cases. Of note, although generally the occurrence of ectopic differentiation is considered a 
characteristic of the WT1-mutant subset of tumours, there are cases known which have 
mutations in CTNNB1 but not in WT1. Instead they lack expression of WT1 and show a gene 
expression signature comparable to the WT1-mutant tumours (for instance tumour set WT-A2 
in Corbin et al., 2009). One could argue these tumours are in effect the same as the WT1-mutant 
tumours, having no functional WT1 protein in combination with a CTNNB1 mutation. 
Although the initiating event would be different (and currently unknown) from the WT1-mutant 
subset, the developmental stage this initiating even would occur would be the same as in Wt1 
mutant tumours. For instance, a gene upstream of WT1 expression at this stage could be 
affected leading to this phenotype. Alternatively, the dedifferentiation of the Wilms’ tumour 
CSCs as described by Shukrun et al (2014) could play a role in the ectopic differentiation found 
in these tumours. Either way, better understanding of this group of tumours could provide 
valuable new insights in the link between stage of origin and Wilms’ tumour phenotype.  
If our interpretation of the Nes-Cre and Pax8+/Cre driven Wt1 mutants and how they 
compare to WT1-mutant and WT1 wild-type tumours is correct, our data also highlights other 
differences between these two tumour groups. Most remarkable is the presence of classic 
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cancer hallmark GO terms in the WT1 wild-type tumour / Pax8+/Cre Wt1 conditional sets but 
absence of these in the Nes-Cre driven mutants / WT1-mutant tumours. A picture emerges 
where the WT1-mutant tumours start as a pure developmental problem, almost like a teratoma 
that is restricted to the mesodermal lineage, whereas the WT1 wild-type tumours are more 
classical cancers right from the start. This difference, if correct, would mean very different 
treatment regiments would be needed to treat these different tumour groups. Indeed, with the 
present therapies the WT1-mutant subset of tumours is much better treatable than their WT1 
wild-type counterpart.  
 In conclusion, we have generated a developmental series of renal Wt1 mutants. The 
data presented here identify the MET and early tubulogenesis stages as developmental steps 
under control of Wt1, suggesting a role as ‘master facilitator’ of kidney development. 
Comparison of the mutant mouse kidney expression data to Wilms’ tumour data is consistent 
with a block in MET as the origin of WT1-mutant Wilms’ tumours and highlights clear 
biological differences between these tumour types. 
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Materials and Methods. 
Mouse lines. All animal experiments were approved by the University of Edinburgh ethical 
committee and according to Home Office legislation. Animal models used were the following. 
Wt1 conditional (Martinez-Estrada et al., 2010): Wt1tm1.1Ndha. Wt1-GFP (Hosen et al., 2007): 
Wt1tm1Nhsn. Nes-Cre (Tronche et al., 1999): Tg(Nes-cre)1Kln. Pax8+/Cre (Bouchard et al., 2004): 
Pax8tm1(cre)Mbu. Wnt4+/CreGFP (Shan et al., 2010): Wnt4tm2(EGFP/cre)Svo. Hoxb7-Cre (Yu et al., 
2002): Tg(Hoxb7-cre)13Amc. Rosa26+/eYFP (Srinivas et al., 2001): Gt(ROSA)26Sortm1(EYFP)Cos. 
Germline Cre mice were a kind gift from Dr. D.J. Kleinjan, IGMM, University of Edinburgh. 
All experiments were done using mice of mixed C57BL/6 / 129Ola background with varying 
generations backcrossing to C57BL/6. 
 
Immunohistochemistry. Embryos were taken at E18.5 and fixed in freshly prepared 4% 
paraformaldehyde overnight at 4ºC. Following fixation the embryos were paraffin embedded, 
sectioned at 7μm and stained with haematoxylin / eosin. Alcian Blue and Alizarin Red staining 
was done as described elsewhere (Bancroft and Stevens, 1990). 
 
Kidney organ cultures. Kidneys at the T-bud stage of development were isolated from E11.5 
embryos and  cultured on 0.4µm pore size Transwell filters in Minimum Essential Medium 
Eagle medium with 10% newborn calf serum, 1% penicillin and streptomycin. For antibody 
staining kidneys were fixed in ice cold methanol for 10mins, washed briefly in PBS and 
blocked in PBS, BSA-Azide overnight at 4°C. Primary antibodies (Pax8 (ProteinTech, cat 
10336-1-AP) 1:200, Pan-Cytokeratin (Sigma, cat C2562) 1:800, E-Cadherin (BD Bioscience, 
cat 610182) 1:800, WT1-C19 (Santa Cruz, cat sc192) 1:200, Megalin (kindly given by Prof. 
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Thomas Willnow, MDC-Berlin) 1:1600, Six2 (LifeSpan Biosciences, LS-C10189) 1:100, 
Ncam1(Sigma, C9672) 1:100 were incubated overnight at 4°C. The following day six 1 hour 
washes in PBST (500ml PBS + 500μl 10% Triton) were carried out at room temperature. 
Secondary antibodies (Alexa Fluor donkey anti-rabbit 594, 1:400 (Invitrogen, cat A21207),  
Alexa Fluor donkey anti-mouse 488 1:400 (Invitrogen, cat A21202) and Alexa Fluor goat anti-
mouse IgG1 (γ1) (for Ncam1 staining, Invitrogen A-21240) were incubated overnight at 4°C, 
followed by six 1 hour washes in PBST, as above. The kidneys were mounted in Vectashield 
mounting medium for fluorescence (Vector Labs, cat H-100). Immunofluorescence was 
observed and recorded on an imaging system comprising of  a Coolsnap HQ CCD camera 
(Photometrics Ltd, Tucson, AZ) Zeiss Axioplan II fluorescence microscope with Plan-neofluar 
objectives of a Nikon A1R confocal microscope. Image capture and analysis were performed 
using in-house scripts written for IPLAB Spectrum (Scanalytics Corp, Fairfax, VA) or 
Fiji/ImageJ.  
The Time Lapse Imaging system comprised a Zeiss Axiovert 200 fluorescence microscope 
(Carl Zeiss, Welwyn, UK), Lambda LS 300W Xenon source and 10-position excitation and 
emission filter wheels (Sutter Instruments, Novato, CA) populated with a Chroma #86000 filter 
set (Chroma Technology Corp., Rockingham, VT), ASI PZ2000 3-axis XYZ stage with 
integrated piezo Z-drive (Applied Scientific Instrumentation, Eugene, OR), Photometrics 
Coolsnap HQ2 CCD camera (Photometrics, Tucson, AZ) and Solent Scientific incubation 
chamber with CO2 enrichment (Solent Scientific, Segensworth, UK). Image capture was 
performed using Metamorph software (Molecular Devices, Sunnyvale, CA). 
The measurements were taken every 10 hours using IPLAB image analysis software 
(Scanalytics, MD, USA) on the still images obtained from the time-lapse movies. In order to 
synchronize the measurements between different kidneys and between different branches, the 
moment that the branch of interest bifurcated was redefined as time 0. 
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 Microarray analysis. Total RNA from E18.5 kidneys using RNAeasy micro columns and on-
column DNase treatment (Qiagen). Samples were labelled using the Illumina® TotalPrep™ 
RNA Amplification Kit (Life technologies) and analysed on Ref8 v2 BeadChips (Illumina). 
Data was analysed using Genespring. All samples were analysed in biological triplicates except 
for Nes-Cre Wt1co/co where one samples failed the analysis QC. Overlaps in differentially 
expressed genes between different mutants were identified using Venny 
(http://bioinfogp.cnb.csic.es/tools/venny/index.html). Geneset enrichment analysis was done 
using ToppGene (http://toppgene.cchmc.org/) and ToppCluster 
(http://toppcluster.cchmc.org/). Networks were manually ordered, categorized  and coloured in 
Cytoscape 3.02 (Smoot et al., 2011).  
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Figures 
 
 
 
1. Lineage tracing of three Cre drivers in cultured kidney rudiments starting from E11.5 
kidneys for the indicated time intervals. Scale bars are 200 µm. A. Nes-Cre 
Rosa26eYFP/eYFP. B. Pax8+/Cre Rosa26eYFP/eYFP. C. Wnt4+/CreGFP Rosa26eYFP/eYFP. 
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2. Renal phenotypes in the three Cre Wt1 conditional models. A-D. H&E stained E18.5 
embryonic kidneys. A. Wt1co/co. B. Nes-Cre Wt1co/co. C. Wnt4+/CreGFP Wt1co/co. D. 
Pax8+/Cre Wt1co/co. CM: cap mesenchyme; CB: comma shaped body; SB: S-shaped 
body; UB: ureteric bud; PT: proximal tubule; DT: distal tubule; EM: expanded 
mesenchyme; IPT: immature proximal tubule. Scale bars 50 µm. E. Macroscopic view 
of Wilms tumour in single surviving Nes-Cre Wt1co/co mouse. Scale bar 10 mm. F. Same 
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tumour as in E with left kidney from the same mouse. Scale bar 10 mm. G. H&E 
staining of tumour in E and F. Scale bar 500 µm. 
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3. Genome-wide expression analysis of E18.5 Nes-Cre Wt1co/co, Wnt4+/CreGFP Wt1co/co and 
Pax8+/Cre Wt1co/co kidneys. A. Comparison at the gene level for increased (left panel) 
and decreased (right panel) genes. Nes-Cre Wt1co/co differential genes are shown in blue, 
Wnt4+/CreGFP Wt1co/co differential genes in yellow and Pax8+/Cre Wt1co/co differential 
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genes in green. B. Enrichment for genesets from cell type / developmental stage-
specific GUDMAP datasets of increased genes in the mutant samples. C. Enrichment 
for genesets from cell type / developmental stage-specific GUDMAP datasets of 
decreased genes in the mutant samples.  D. Enrichment for biological processes (green 
nodes) and human / mouse phenotypes (brown nodes) coupled to genes increased in the 
mutant genotypes. E. Enrichment for biological processes (green nodes)  and human / 
mouse phenotypes (brown nodes) coupled to genes decreased in the mutant genotypes.  
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4. Time-lapse analysis of control and conditional Wt1 mutants for indicated time-points. 
A. Wt1co/GFP (control). B. Nes-Cre Wt1co/GFP. C. Pax8+/Cre Wt1co/GFP. Scale bars are 200 
µm. 
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5. Antibody staining of cultured kidney rudiments (E11.5 + 6 days in culture) for Wt1, E-
cadherin (E-cad), Pax8, pan-Cytokeratin (pan-CK) and Megalin. Genotypes and 
antibodies are indicated.  
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6.  Antibody staining for nephron progenitor markers (E11.5 + 6 days in culture).Wt1GFP 
signal, antibodies and genotypes as indicated. Arrow indicates loose disorganized cap 
mesenchyme, asterisk indicates mesenchymal Wt1GFP-positive cells outside the cap 
mesenchyme. Scale bar indicates 100  
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7.  Branching phenotype in Wt1 mutants. A. Quantification of branch length, width and 
angle using time-lapse analysis. Two independent mutant and control kidneys were 
analysed and shown individually. T=0 is the moment a branch formed. Error bars 
indicate the SEM of different branches in the same kidney, n >= 6. P-values were 
calculated using a two-tailed Student’s t-distribution. B. pan-Cytokeratin antibody 
staining in indicated genotypes (E11.5 + 6 day culture). Scale bars are 200 µm. C. 
Recombination experiments between wild-type mesenchymes and Pax8+/Cre mutant 
ureteric buds stained for calbindin-D-28k antibodies. Scale bars are 100 µm. Panel 1: 
wild-type kidney (E11.5 + 2 day culture). Panel 2: Pax8+/Cre Wt1co/co kidney (E11.5 + 2 
day culture). Panel 3: Recombined wild-type mesenchymes with mechanically 
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dissected Pax8+/Cre Wt1co/co ureteric buds (E11.5 + 2 day culture). Panel 4: Recombined 
wild-type mesenchymes with mechanically dissected Pax8+/Cre Wt1co/co ureteric buds 
(E11.5 + 2 day culture). 
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8. Comparison of Nes-Cre Wt1co/co, Pax8+/Cre Wt1co/co, WT1-mutant and WT1-wild-type 
Wilms’ tumour microarray data. A. Comparison at the gene level. The 13 genes in the 
Nes-Cre Wt1co/co / WT1-mutant Wilms’ tumour overlap that give enrichment for muscle 
functions (see main text) are indicated. B. Comparison at the GO-term ‘biological 
process’. Red nodes: muscle-related. Light blue nodes: bone/cartilage-related. Yellow 
nodes: apoptosis-related. Grey nodes: kidney development-related. Green nodes: 
Histone modification-related. Orange nodes: Cell cycle-related. C. Alcian Blue / 
Alzarin Red staining of E18.5 sections. Scale bars indicate 50 µm.  
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 Translational Impact. 
Clinical issue. Wilms’ tumours are childhood kidney cancers that originate from problems 
during kidney development before birth. Different subgroups of tumours have been described 
that show different responses to therapy and clinical outcomes. Identifying the developmental 
stage of origin of Wilms’ tumours will allow the design of new and improved therapies based 
on our understanding of normal kidney development. Genome-wide expression analysis of 
tumours has suggested different stages of origin for different subsets, but this has not been 
experimentally validated. 
Results. The genetically best-defined subset is the group of tumours that is caused by loss of 
the WT1 tumour suppressor gene. We have used a conditional Wt1 knockout mouse model to 
remove the gene from three different stages of kidney development. Our results show that 
losing Wt1 at each of these stages results in disruption of kidney development at different 
stages and death of the pups immediately after birth. We compared genome-wide expression 
patterns of the mutant kidneys to expression patterns of human WT1-mutant and WT1 wild-
type Wilms’ tumours and found that the mutant where nephron development is blocked before 
the mesenchymal to epithelial transition (MET) most closely resembles the WT1-mutant 
tumours while the mutant with a post-MET block more closely resembles the expression 
pattern found in WT1 wild-type tumours.  
Implications and future directions. Although our experimental data confirms that subgroups of 
Wilms’ tumours have different stages of origin, the stages we find experimentally are different 
from the ones deduced from tumour gene expression patterns. This finding would change our 
ideas on the biological causes of Wilms’ tumours and will impact the biological pathways that 
should be targeted in the different subgroups of tumours. 
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